Processa Pharmaceuticals Inc (PCSA)
1.80
+0.04
(+2.27%)
USD |
NASDAQ |
May 24, 16:00
1.80
0.00 (0.00%)
After-Hours: 20:00
Processa Pharmaceuticals Price to Book Value: 0.5791 for May 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 24, 2024 | 0.5791 |
| May 23, 2024 | 0.5662 |
| May 22, 2024 | 0.592 |
| May 21, 2024 | 0.6113 |
| May 20, 2024 | 0.6241 |
| May 17, 2024 | 0.6306 |
| May 16, 2024 | 0.6435 |
| May 15, 2024 | 0.6499 |
| May 14, 2024 | 0.7014 |
| May 13, 2024 | 0.7142 |
| May 10, 2024 | 0.6724 |
| May 09, 2024 | 0.6853 |
| May 08, 2024 | 0.7979 |
| May 07, 2024 | 0.7979 |
| May 06, 2024 | 0.756 |
| May 03, 2024 | 0.6981 |
| May 02, 2024 | 0.7271 |
| May 01, 2024 | 0.7142 |
| April 30, 2024 | 0.7013 |
| April 29, 2024 | 0.6756 |
| April 26, 2024 | 0.6912 |
| April 25, 2024 | 0.7813 |
| April 24, 2024 | 0.5208 |
| April 23, 2024 | 0.5144 |
| April 22, 2024 | 0.4919 |
| Date | Value |
|---|---|
| April 19, 2024 | 0.508 |
| April 18, 2024 | 0.5015 |
| April 17, 2024 | 0.5337 |
| April 16, 2024 | 0.4951 |
| April 15, 2024 | 0.4871 |
| April 12, 2024 | 0.5369 |
| April 11, 2024 | 0.5658 |
| April 10, 2024 | 0.5916 |
| April 09, 2024 | 0.9356 |
| April 08, 2024 | 0.9597 |
| April 05, 2024 | 0.897 |
| April 04, 2024 | 0.7459 |
| April 03, 2024 | 0.7587 |
| April 02, 2024 | 0.8166 |
| April 01, 2024 | 0.7555 |
| March 28, 2024 | 1.354 |
| March 27, 2024 | 1.299 |
| March 26, 2024 | 1.242 |
| March 25, 2024 | 1.288 |
| March 22, 2024 | 1.282 |
| March 21, 2024 | 1.242 |
| March 20, 2024 | 0.7633 |
| March 19, 2024 | 0.7736 |
| March 18, 2024 | 0.7838 |
| March 15, 2024 | 0.7496 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4871
Minimum
Apr 15 2024
16.21
Maximum
Dec 15 2020
2.977
Average
2.154
Median
Price to Book Value Benchmarks
| DIH Holding US Inc | -- |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 20.44 |
| iBio Inc | 0.7596 |
| Theriva Biologics Inc | 0.1684 |
Price to Book Value Related Metrics
| Price | 1.80 |
| Earnings Yield | -355.0% |
| Market Cap | 5.144M |